Clorpheniramin Vidipha treatment of allergic rhinitis, year -round and urticaria (10 blisters x 20 tablets)
Dosage form Tablet
Specifications Box of 10 blisters x 20 tablets
Ingredient Chlorpheniramin Maleat
Indication Urticaria, itching, atopic dermatitis, contact dermatitis, sneezing, stuffy nose
Ingredient
| Composition information | Content |
| Chlorpheniramin Maleat | 4mg |
Uses
Indications
Clorpheniramin 4mg Vidipha is indicated in the following cases:
Chlorpheniramin Maleat and dexclorpheniramin maleat are used to treat symptoms of allergies such as urticaria, angioedema, allergic rhinitis, allergic membranes, itching. The drug is a common ingredient to treat coughs and colds. However, these preparations must be used carefully for children and often have to avoid for children under two years of age, because of the risk of death.
pharmacokinetic
absorption
Clorpheniramin Maleat absorbs well but is relatively slow because the drug is highly metabolized in the gastrointestinal mucosa and initially metabolic in the liver when drinking and appears in plasma within 30-60 minutes. The concentration of wall peaks is reached for about 2.5 to 6 hours after drinking. About 5 - 45% of the single dose is completely in the form of non -metabolic drugs. Low bioavailability, reaching 25-50%.
Distribution
About 70% of the drug during the circulation is linked to the protein. The distribution volume is about 2.5 to 3.2 liters/kg (adults) and 3.8 liters/kg (children).
Metabolism
chlorpheniramin maleat is fast and highly metabolized. The metabolites include Desmethyl-Didesmethyl-Corpheniramin and some unknown substances, one or more substances of which are active. The concentration of chlorpheniramine in serum is not correlated in accordance with the antihistamine effect because there is an unknown metabolic substance that also works.
Elimination
The drug is excreted mainly in urine in a constant or metabolic form, the excretion depends on the pH and the urine flow. Reduces excretion times when pH pH increases and urine flow decreases. Only a small amount is seen in the feces. Adults have normal liver and kidney function, chlorpheniramin waste time ranges from 12 to 43 hours and for children from 5.2 - 23.1 hours. In patients with chronic renal insufficiency, the selling time lasts up to 280 - 330 hours.
Before taking Clorpheniramin Vidipha treatment of allergic rhinitis, year -round and urticaria (10 blisters x 20 tablets)
How to use
Clorpheniramin 4mg used by oral.
Dosage
Adults and children over 12 years: 1 tablet every 4 - 6 hours. Maximum daily dose: 6 tablets (24mg) for 24 hours.
The elderly, the elderly are prone to anti -cholin effects on the nervous system. It is necessary to consider lower daily doses (for example, maximum of 12mg in 24 hours).
Children from 6 - 12 years old: 1/2 tablets every 4-6 hours. Maximum daily dose: 3 tablets (12mg) for 24 hours.
Do not use for children under 6 years old.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when using overdose?
Treatment of symptoms and supporting life function should pay attention to liver, kidney, respiratory, heart and water balance. Stomach lavage or caused by ipecacuanha syrup. After that, use activated carbon and western medicine to limit absorption. When experiencing hypotension and arrhythmia, it should be actively treated. It is possible to treat convulsions by intravenous diazepam or phenytoin intravenously, which may need blood transfusions in heavy cases.
What to do when forgetting a dose? But if it's almost time for the next dose, only use the following dose. Do not use the dose or add the dose to compensate immediately forget to drink.
Side Effects
When using Clorpheniramin 4mg Vidipha you may experience unwanted effects (ADR).
Very common, ADR> 1/10
Common,
When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Clorpheniramin 4mg Vidipha drugs are contraindicated in the following cases:
Precautions when used
The drug increases the risk of urination in people with prostate hypertrophy, urinary tract congestion, pyloric garges and people with myastheniasticks.
The sedative effect of chlorpheniramine increases when drinking alcohol or drinking simultaneously with other sedatives.There is a risk of respiratory complications, respiratory decline and apnea in people with pulmonary obstruction or children. Precautions when chronic lung disease, shortness of breath or shortness of breath.
There is a risk of tooth decay in the person treating for a long time.
Avoid using patients with glaucoma as glaucoma.
can cause chicken sleep, dizziness, dizziness, blurred vision and mental impairment in some patients.
Elderly.
Do not use for patients with galactose intolerance, lactase deficiency, Glucose-Galactose absorption disorders.
Need to monitor patients when using the drug because the drug contains Tartrazin yellow excipients that can cause allergic reactions.
The ability to drive and operate machinery
Do not take the drug when driving or operating machinery because the drug can cause unwanted effect to sleep, dizziness, dizziness.
Pregnancy
only used when really necessary. Using drugs in the last 3 months of pregnancy can lead to serious reactions (such as epilepsy) in newborns.
Breastfeeding period
Clorpheniramin can be secreted through breast milk and inhibit milk. Should consider or do not breastfeed or do not take the drug, depending on the level of need for the drug for the mother.
Medicinal interaction
Monoamine oxydase inhibitors prolonged and increased anti -secretion effects of antihistamines.
ethanol or sedative drugs can increase the effect of inhibiting the central nervous system of chlorpheniramin.
chlorpheniramine inhibits phenytoin metabolism and can lead to phenytoin poisoning.
Storage
Store in a dry place, the temperature does not exceed 30 ° C, avoiding light.
Other drugs
- Eucreas
- FERROGRAD C TABLETS
- HARTMANNS SOLUTION
- K/L POULTICE (KAOLIN POULTICE BP)
- RHINATHIOL SYRUP 250MG/5ML
- ZYDOL 50MG CAPSULES
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions